These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 19651236)
1. Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: etiopathogenic similarities, differences and paradoxes. Porta M; Crous-Bou M; Wark PA; Vineis P; Real FX; Malats N; Kampman E Mutat Res; 2009; 682(2-3):83-93. PubMed ID: 19651236 [TBL] [Abstract][Full Text] [Related]
2. K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung. Westra WH; Slebos RJ; Offerhaus GJ; Goodman SN; Evers SG; Kensler TW; Askin FB; Rodenhuis S; Hruban RH Cancer; 1993 Jul; 72(2):432-8. PubMed ID: 8319174 [TBL] [Abstract][Full Text] [Related]
3. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Rodenhuis S; Slebos RJ; Boot AJ; Evers SG; Mooi WJ; Wagenaar SS; van Bodegom PC; Bos JL Cancer Res; 1988 Oct; 48(20):5738-41. PubMed ID: 3048648 [TBL] [Abstract][Full Text] [Related]
4. Lung cancer and past occupational exposure to asbestos. Role of p53 and K-ras mutations. Husgafvel-Pursiainen K; Karjalainen A; Kannio A; Anttila S; Partanen T; Ojajärvi A; Vainio H Am J Respir Cell Mol Biol; 1999 Apr; 20(4):667-74. PubMed ID: 10100998 [TBL] [Abstract][Full Text] [Related]
5. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632 [TBL] [Abstract][Full Text] [Related]
6. Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer. Crous-Bou M; Porta M; López T; Jariod M; Malats N; Alguacil J; Morales E; Fernandez E; Corominas JM; Carrato A; Guarner L; Real FX; Pancreas; 2007 Aug; 35(2):135-41. PubMed ID: 17632319 [TBL] [Abstract][Full Text] [Related]
7. k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis. Nelson HH; Christiani DC; Wiencke JK; Mark EJ; Wain JC; Kelsey KT Cancer Res; 1999 Sep; 59(18):4570-3. PubMed ID: 10493509 [TBL] [Abstract][Full Text] [Related]
8. Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers. Toyooka S; Tokumo M; Shigematsu H; Matsuo K; Asano H; Tomii K; Ichihara S; Suzuki M; Aoe M; Date H; Gazdar AF; Shimizu N Cancer Res; 2006 Feb; 66(3):1371-5. PubMed ID: 16452191 [TBL] [Abstract][Full Text] [Related]
9. Frequency and spectrum of K-RAS codons 12 and 13 mutations in colorectal adenocarcinomas from Taiwan. Wu CM; Tang R; Wang JY; Changchien CR; Hsieh LL Cancer Genet Cytogenet; 2005 Apr; 158(1):55-60. PubMed ID: 15771905 [TBL] [Abstract][Full Text] [Related]
10. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review. Minamoto T; Mai M; Ronai Z Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118 [TBL] [Abstract][Full Text] [Related]
11. Differences in K-ras and p53 gene mutations among pancreatic adenocarcinomas associated with regional environmental pollution. Soliman AS; Lo AC; Banerjee M; El-Ghawalby N; Khaled HM; Bayoumi S; Seifeldin IA; Abdel-Aziz A; Abbruzzese JL; Greenson JK; Hamilton SR Carcinogenesis; 2007 Aug; 28(8):1794-9. PubMed ID: 17575320 [TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression. Pulling LC; Divine KK; Klinge DM; Gilliland FD; Kang T; Schwartz AG; Bocklage TJ; Belinsky SA Cancer Res; 2003 Aug; 63(16):4842-8. PubMed ID: 12941804 [TBL] [Abstract][Full Text] [Related]
13. Cigarette smoking and KRAS oncogene mutations in sporadic colorectal cancer: results from the Netherlands Cohort Study. Weijenberg MP; Aardening PW; de Kok TM; de Goeij AF; van den Brandt PA Mutat Res; 2008 Mar; 652(1):54-64. PubMed ID: 18296105 [TBL] [Abstract][Full Text] [Related]
14. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms. Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499 [TBL] [Abstract][Full Text] [Related]
15. K-ras 4A and 4B are co-expressed widely in human tissues, and their ratio is altered in sporadic colorectal cancer. Plowman SJ; Berry RL; Bader SA; Luo F; Arends MJ; Harrison DJ; Hooper ML; Patek CE J Exp Clin Cancer Res; 2006 Jun; 25(2):259-67. PubMed ID: 16918139 [TBL] [Abstract][Full Text] [Related]
16. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers. Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617 [TBL] [Abstract][Full Text] [Related]
17. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983 [TBL] [Abstract][Full Text] [Related]
18. Interaction between smoking and asbestos in human lung adenocarcinoma: role of K-ras mutations. Vainio H; Husgafvel-Pursiainen K; Anttila S; Karjalainen A; Hackman P; Partanen T Environ Health Perspect; 1993 Oct; 101 Suppl 3(Suppl 3):189-92. PubMed ID: 8143615 [TBL] [Abstract][Full Text] [Related]
19. K-ras mutations in human adenocarcinoma of the lung: association with smoking and occupational exposure to asbestos. Husgafvel-Pursiainen K; Hackman P; Ridanpää M; Anttila S; Karjalainen A; Partanen T; Taikina-Aho O; Heikkilä L; Vainio H Int J Cancer; 1993 Jan; 53(2):250-6. PubMed ID: 8425762 [TBL] [Abstract][Full Text] [Related]
20. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Westra WH; Baas IO; Hruban RH; Askin FB; Wilson K; Offerhaus GJ; Slebos RJ Cancer Res; 1996 May; 56(9):2224-8. PubMed ID: 8616876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]